Ursolic Acid Reverses the Chemoresistance of Breast Cancer Cells to Paclitaxel by Targeting MiRNA-149-5p/MyD88

Paclitaxel (PTX) is widely used as a front-line chemotherapy for breast cancer treatment. However, its clinical applications are limited by the development of chemoresistance. The objective of this study was to investigate the reversal effects of ursolic acid (UA) on PTX resistance and the possible...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Fenfen, Fan, Yan, Ni, Zhenhua, Liu, Qiaoli, Zhu, Zhaowei, Chen, Zixi, Hao, Wenbin, Yue, Honghong, Wu, Rong, Kang, Xiangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587017/
https://www.ncbi.nlm.nih.gov/pubmed/31259152
http://dx.doi.org/10.3389/fonc.2019.00501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587017/
https://www.ncbi.nlm.nih.gov/pubmed/31259152
http://dx.doi.org/10.3389/fonc.2019.00501

Ejemplares similares